Translate this page into:
Impact of cytopathology authors work: Comparative analysis based on Open-access cytopathology publications versus non-Open-access conventional publications
*Corresponding author: Janavi A. Kolpekwar, Research Assistant, Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, United States. jkolpekwar@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Kolpekwar JA, Shidham VB. Impact of cytopathology authors work: Comparative analysis based on Open-access cytopathology publications versus non-Open-access conventional publications. CytoJournal 2021;18:20.
Abstract
Objectives:
Open access (OA) is based on a set of principles and a range of practices through which fruits of research are distributed online, free of cost, or other access barriers. According to the 2001 definition, OA publications are without barriers to copy or reuse with free access to readers. Some studies have reported higher rates of citation for OA publications. In this study, we analyzed the citation rates of OA and traditional nonOA (with or without free access) publications for authors publishing in the subspecialty of cytopathology during 2010–2015.
Material and Methods:
We observed and compared citation patterns for authors who had published in both OA and traditional non-OA, peer-reviewed, scientific, cytopathology journals. Thirty authors were randomly selected with criteria of publishing a total of at least five cytopathology articles over 2010–2015. Number of citations per article (CPA) (during 2010–2015) for OA publications (in CytoJournal and Journal of Cytology) and non-OA publications (in Diagnostic Cytopathology, Cytopathology, Acta Cytologica, Journal of American of Cytopathology, and Indian Journal of Pathology and Microbiology) was collected and compared statistically using two-tailed Student’s t-est. The data were collected manually through science citation analysis sites, mostly Google Scholar.
Results:
Thirty authors published 579 cytopathology articles in OA and non-OA journals. Average CPA for OA publications was 26.64. This was 11.35 higher than the average CPA) of non-OA conventional with subscription cytopathology journals (74% increase) and 11.76 higher than the average CPA of conventional cytopathology non-OA journal articles with free access (79% increase). These differences were statistically significantly with P < 0.05.
Conclusion:
We observed that the cytopathology publications in the OA journal attained a higher rate of CPA than the publications in the traditional non-OA journals in the field of cytopathology during 2010–2015.
Keywords
Open access
Cytopathology
Journal
CytoJournal
INTRODUCTION
As defined by Peter Suber: “Open-access (OA) literature is digital, online, free of charge, and free of most copyright and licensing restrictions.”[1,2] Thus, OA platform extends benefits to both readers (in general by removing cost barriers such as pay-per-view fees, subscriptions, and licensing fees) and authors by softening the permission barriers related to most copyright and licensing restrictions. In nutshell, OA allows free dissemination with barrier-free academic recycling for best productivity.[3-7]
The conventional model of publishing and disseminating scientific research has served the purpose with public good over a long period, especially in the era before advances in internet. Any model of scientific literature is dependent on the willingness of scholars to publish their work. In the traditional model, the authors could publish without paying, because the copyright to work is taken by the publisher to be sold for revenue generation. However, this restricts the access of their work by public without ability to pay. This is in contrast to the general expectation of authors that their work should be widely disseminated and freely available. In addition, the loss of copyright compromises the long-term interests of authors and public without freedom to use this work for later use.
Barrier-free access to scientific literature would enhance research and enrich scholarly activities by easy sharing for learning irrespective of financial resources. This will ultimately strengthen the scientific foundations and progress in the quest for knowledge.
In a small subspecialty field like cytopathology, the majority of journals are traditional-type publications. The hypothesis of this study entails that the publications in OA Cytopathology Journal under the OA charter would have higher rate of citation per article (CPA)[8] as compared to the publications in the traditional non-OA cytopathology journals.[3] This study evaluates the impact of publishing in OA by individual authors in recent times after relatively established role of OA in cytopathology.
MATERIAL AND METHODS
The data about citations for cytopathology articles were collected from the Google Scholar search database with additional help from other databases such as PubMed[9] over a 5-year time period (2010–2015).
Multiple authors publishing in cytopathology subject area were randomly selected. Only 30 of these, who fulfilled the following criteria were included in this study:
Those who published at least five total articles (OA and non-OA publications) [Figure 1] during 2010–2015.
Those who were not editors/coeditors of the journals under the study during 2010–2015.
OA journal was put in category #1. Non-OA publications (category #2) were split further into category #2A: Available with paid subscription without free access and category #2B: Non-OA publications with free access [Figure 1 and Table 1].
I | II | III | IV | V | VI | VII |
---|---|---|---|---|---|---|
S. No. | Author | Category | Articles | Total citations | Average citation per article |
Remark (Year–citations) |
1. | Shipra Agrawal | 1 | 4 | 22 | 5.50 | 2011–5, 2011–6, 2014–8, 2015–3 |
2A | 2 | 8 | 4 | 2012–6, 2014–2 | ||
2B | 1 | 2 | 2 | 2012–2 | ||
2. | Manon Auger | 1 | 17 | 356 | 20.94 | 2010–8, 2010–6, 2012–23, 2012–0, 2012–4, 2012–65, 2013–21, 2013–12, 2013–29, 2013–87, 2014–11, 2014–0, 2014–8, 2014–28, 2015–19, 2015–12, 2015–23 |
2A | 7 | 140 | 20 | 2010–10, 2010–17, 2013–14, 2014–84, 2014–12, 2015–0, 2015–3 |
||
2B | 7 | 52 | 7.43 | 2010–21, 2011–9, 2014–0, 2015–7, 2015–11, 2015–3, 2015–1 | ||
3. | R.M. Austin | 1 | 17 | 291 | 17.11 | 2010–10, 2011–30, 2011–16, 2011–10, 2012 |
2A | 6 | 51 | 8.50 | 2012–21, 2012–0, 2014–6, 2015–13, 2015–10, 2015–1 | ||
2B | 10 | 170 | 17 | 2011–7, 2011–70, 2012–27, 2013–16, 2013–13, 2013–1, 2014–17, 2015–13, 2015–5, 2015–1 | ||
4. | Zubair W. Baloch | 1 | 13 | 1653 | 127.15 | 2011–4, 2011–65, 2011–32, 2012–116, 2012–33, 2012–1058, 2013–6, 2014–101, 2014–35, 2015–40, 2015–42, 2015–11, 2015–110 |
2A | 6 | 52 | 8.67 | 2012–3, 2013–13, 2014–4, 2015–0, 2015–23, 2015–9 | ||
2B | 11 | 912 | 82.91 | 2010–23, 2010–10, 2010–0, 2010–1, 2012–780, 2012–9, 2014–30, 2014–14, 2015–6, 2015–15, 2015–24 | ||
5. | Joel S. Bentz | 1 | 9 | 214 | 23.78 | 2010–42, 2010–9, 2010–10, 2010–20, 2011–26, 2011–5, 2013–44, 2015–35, 2015–23 |
2A | 1 | 14 | 14 | 2015–14 | ||
2B | 2 | 14 | 7 | 2011–8, 2015–6 | ||
6. | Fadi Brimo | 1 | 5 | 314 | 62.8 | 2010–16, 2010–14, 2014–23 |
2A | 5 | 114 | 22.8 | 2010–2, 2014–84, 2014–19, 2015–9, 2015–0 | ||
2B | 2 | 2 | 1 | 2014–0, 2014–2 | ||
7. | Robert A Goulart | 1 | 3 | 53 | 17.67 | 2010–16, 2010–14, 2014–23 |
2A | 4 | 30 | 7.50 | 2010–5, 2011–11, 2011–0, 2014–14 | ||
2B | 2 | 6 | 3 | 2014–0, 2014–6 | ||
8. | Prabodh K Gupta | 1 | 3 | 59 | 19.67 | 2015–13, 2015–34, 2015–12 |
2A | 1 | 7 | 7 | 2015–7 | ||
2B | 1 | 12 | 12 | 2014–12 | ||
9. | Rana S. Hoda | 1 | 7 | 235 | 33.57 | 2012–28, 2012–7, 2013–46, 2013–84, 2014–59, 2015–4, 2015–7 |
2A | 12 | 182 | 15.17 | 2010–16, 2010–9, 2011–70, 2011–0, 2012–7, 2013–12, 2014–17, 2014–0, 2014–23, 2015–0, 2015–9, 2015–19 | ||
2B | 1 | 6 | 6 | 2015–6 | ||
10. | Venkateswaran K Iyer | 1 | 12 | 270 | 22.50 | 2010–12, 2011–5, 2012–90, 2012–3, 2012–0, 2013–3, 2013–27, 2014–24, 2014–15, 2015–34, 2015–18, 2015–39 |
2A | 9 | 76 | 8.44 | 2010–23, 2012–6, 2013–13, 2013–3, 2013–0, 2014–14, 2015–8, 2015–9, 2015–0 | ||
2B | 1 | 3 | 3 | 2010–3, | ||
11. | Darshana N. Jhala | 1 | 5 | 166 | 33.20 | 2011–85, 2011–63, 2014–13, 2014–5, 2015–0 |
2A | 6 | 66 | 11 | 2010–15, 2011–4, 2011–8, 2011–10, 2013–27, 2015–2 | ||
2B | 5 | 42 | 8.4 | 2010–2, 2011–0, 2012–0, 2015–21, 2015–19 | ||
12. | Walid Khalbuss | 1 | 21 | 518 | 24.67 | 2010–52, 2010–34, 2010–20, 2010–9, 2010–13, 2011–21, 2011–22, 2011–13, 2011–11, 2011–12, 2011–14, 2011–11, 2012–52, 2012–18, 2012–9, 2013–34, 2013–95, 2013–18, 2013–9, 2014–38, 2015–13 |
2A | 16 | 299 | 18.69 | 2010–11, 2010–19, 2010–2, 2011–15, 2011–8, 2011–7, 2012–126, 2012–3, 2013–3, 2013–14, 2013–6, 2014–15, 2014–12, 2015–23, 2015–21, 2015–14 | ||
2B | 8 | 134 | 16.75 | 2010–17, 2011–63, 2011–2, 2012–0, 2012–6, 2012–12, 2014–15, 2015–19 | ||
13. | Sandeep Mathur | 1 | 6 | 135 | 22.50 | 2011–28, 2012–8, 2012–3, 2013–49, 2013–34, 2013–13 |
2A | 6 | 70 | 11.67 | 2010–10, 2011–14, 2012–12, 2013–12, 2013–10, 2015–12 | ||
2B | 6 | 26 | 4.33 | 2010–6, 2012–7, 2012–7, 2013–3, 2013–0, 2015–3 | ||
14. | Pam Michelow | 1 | 6 | 98 | 16.33 | 2010–42, 2010–9, 2011–15, 2011–1, 2012–18, 2015–13 |
2A | 5 | 52 | 10.40 | 2010–20, 2011–5, 2011–4, 2011–15, 2013–8, | ||
2B | 3 | 21 | 7 | 2014–0, 2014–9, 2015–12 | ||
15. | Sara Monoca | 1 | 16 | 457 | 28.56 | 2010–63, 2010–21, 2010–9, 2010–52, 2011–11, 2011–22, 2011–43, 2011–12, 2011–14, 2012–48, 2012–18, 2013–18, 2013–19, 2014–83, 2014–21, 2014–3 |
2A | 10 | 280 | 28 | 2011–13, 2011–15, 2011–8, 2012–126, 2012–10, 2013–43, 2014–14, 2014–38, 2015–7, 2015–6 | ||
2B | 3 | 83 | 27.67 | 2013–47, 2014–15, 2015–21 | ||
16. | Liron Pantanowitz | 1 | 15 | 432 | 28.80 | 2011–85, 2011–11, 2011–22, 2011–12, 2011–14, 2011–13, 2012–18, 2012–21, 2013–29, 2013–18, 2014–18–2014–8, 2014–15, 2014–79, 2015–69 |
2A | 10 | 219 | 21.90 | 2010–15, 2010–14, 2011–63, 2011–15, 2012–48, 2013–13, 2014–19, 2014–4, 2015–7, 2015–21 | ||
2B | 4 | 78 | 19.50 | 2011–0, 2012–39, 2014–38, 2015–1 | ||
17. | Bharat Rekhi | 1 | 20 | 313 | 15.65 | 2010–13, 2010–11, 2010–2, 2010–17, 2010–0, 2011–28, 2011–22, 2012–2, 2012–41, 2013–8, 2013–6, 2013–39, 2014–32, 2014–12, 2014–1, 2014–2, 2014–29, 2015–0, 2015–23, 2015–25 |
2A | 6 | 66 | 11 | 2010–4, 2012–0, 2013–54, 2014–4, 2015–3, 2015–1 | ||
2B | 6 | 91 | 15.12 | 2010–57, 2013–0, 2014–0, 2014–15, 2015–16, 2015–3 | ||
18. | Torill Sauer | 1 | 8 | 156 | 19.5 | 2010–15, 2010–18, 2012–18, 2012–9, 2014–6, 2015–34, 2015–44, 2015–12 |
2A | 5 | 95 | 19 | 2011–41, 2014–12, 2014–10, 2014–9, 2015–23 | ||
2B | 2 | 29 | 14.5 | 2011–22, 2015–7 | ||
19. | Michael J. Thrall | 1 | 8 | 148 | 18.5 | 2010–12, 2010–32, 2012–37, 2013–2, 2013–0, 2015–22, 2015–1, 2015–42 |
2A | 4 | 48 | 12 | 2010–27, 2014–13–2014–4, 2014–4 | ||
2B | 1 | 5 | 5 | 2014–5 | ||
20. | Neda A. Moatamed | 1 | 7 | 112 | 16 | 2012–5, 2012–24, 2013–5, 2013–14, 2014–12, 2015–7, 2015–45 |
2A | 4 | 29 | 7.25 | 2011–8, 2013–12, 2013–0, 2015–9 | ||
2B | 1 | 9 | 9 | 2011–9, | ||
21. | Radhika Srinivasan | 1 | 15 | 352 | 23.47 | 2010–10, 2010–7, 2011–8, 2012–24, 2012–30, 2012–18, 2012–25, 2012–33, 2013–49, 2013–14, 2014–17, 2015–62, 2015–20, 2015–7, 2015–28 |
2A | 6 | 132 | 22 | 2010–24, 2010–36, 2012–16, 2013–15, 2015–35, 2015–6 | ||
2B | 5 | 109 | 21.8 | 2010–42, 2011–22, 2012–6, 2012–20, 2013–19 | ||
22. | Fernando Schmitt | 1 | 12 | 307 | 25.58 | 2010–19, 2012–19, 2012–59, 2013–13, 2013–19, 2013–8, 2014–49, 2014–27, 2014–14, 2014–20, 2015–27, 2015–23 |
2A | 6 | 105 | 17.5 | 2013–5, 2013–21, 2014–11, 2014–41, 2015–8, 2015–19 | ||
2B | 4 | 57 | 14.25 | 2011–16, 2013–25, 2014–7, 2014–9 | ||
23. | Esther Diana Rossi | 1 | 11 | 500 | 45.45 | 2011–117, 2013–60, 2013–29, 2013–19, 2014–27, 2014–46, 2014–14, 2015–77, 2015–65, 2015–18, 2015–28 |
2A | 6 | 247 | 41.17 | 2011–103, 2013–86, 2013–6, 2013–2, 2015–37, 2015–13 | ||
2B | 2 | 55 | 27.5 | 2010–36, 2015–19 | ||
24. | Manju Kaushal | 1 | 5 | 55 | 11 | 2010–4, 2012–25, 2015–16, 2015–5, 2015–5 |
2A | 2 | 12 | 6 | 2015–5, 2015–7 | ||
2B | 2 | 13 | 6.5 | 2015–11, 2015–2 | ||
25. | Vijay Kumar | 1 | 4 | 103 | 25.75 | 2011–39, 2014–27, 2015–2, 2015–35 |
2A | 1 | 6 | 6 | 2015–6 | ||
2B | 1 | 11 | 11 | 2015–11 | ||
26. | Hussain A. Saleh | 1 | 9 | 177 | 19.67 | 2010–7, 2010–22, 2013–29, 2013–12, 2013–5, 2014–13, 2014–39, 2014–23, 2015–27 |
2A | 6 | 192 | 32 | 2010–124, 2011–0, 2014–23, 2014–14, 2014–2, 2015–29 | ||
2B | 1 | 5 | 5 | 2015–5 | ||
27. | Savitri Krishnamurthy | 1 | 7 | 85 | 12.14 | 2010–16, 2013–41, 2013–3, 2014–3, 2014–2, 2015–19, 2015–1 |
2A | 4 | 69 | 17.25 | 2011–26, 2014–19, 2014–11, 2014–13, | ||
2B | 4 | 8 | 2 | 2015–5, 2015–2, 2015–0, 2015–1 | ||
28. | Nalini Gupta | 1 | 9 | 180 | 20 | 2010–16, 2010–7, 2011–18, 2012–24, 2012–16, 2012–9, 2012–8, 2015–62, 2015–29 |
2A | 7 | 118 | 16.85 | 2011–22, 2012–30, 2012–10, 2012–25, 2014–11, 2015–17, 2015–3 | ||
2B | 3 | 126 | 42 | 2010–42, 2012–70, 2015–14 | ||
29. | Raje Nijhawan | 1 | 14 | 316 | 22.57 | 2010–5, 2011–40, 2012–9, 2012–30, 2012–19, 2012–13, 2012–16, 2013–14, 2014–50, 2014–28, 2015–62, 2015–20, 2015–13, 2015–7 |
2A | 9 | 160 | 17.78 | 2010–16, 2010–7, 2011–22, 2011–25, 2012–24, 2012–18, 2012–16, 2013–15, 2015–17 | ||
2B | 4 | 101 | 25.25 | 2010–19, 2010–4, 2011–53, 2012–25, | ||
30. | Pranab Dey | 1 | 7 | 134 | 19.14 | 2011–14, 2012–24, 2013–14, 2014–20, 2014–13, 2015–26, 2015–23 |
2A | 7 | 106 | 15.14 | 2011–23, 2011–16, 2012–30, 2015–20, 2015–13, 2015–4, 2015–0 | ||
2B | 2 | 45 | 22.5 | 2012–43, 2015–2 |
We observed and compared citation patterns during 2010–2015 for authors who had published in both OA and traditional non-OA peer-reviewed, scientific cytopathology journals.[3] Citation data for OA publications (CytoJournal and Journal of Cytology) and traditional nonOA cytopathology journals (Diagnostic Cytopathology, Cytopathology, Acta Cytologica, Journal of American of Cytopathology, and Indian Journal of Pathology and Microbiology) were mined from science citation analysis sites, mostly Google Scholar with a few more sites such as PubMed. Google Scholar is a very large database with over 389 million records, and it includes all of the relevant and credible journals in the field of cytopathology. The database is also “publisher neutral” as it does not favor one commercial, OA, or societal and university publication over the other.
The data as of July 2021 were recorded in Excel spreadsheet with formulated calculations for citation per article averages. Citations for each cytopathology publication for each author were noted and categorized by the publication year. The accumulated data during 2010–2015 for all 30 authors are shown in Table 1. Averages of CPA for the three publication types were statistically compared with two-tailed Student’s t-test [Table 2].[10] The significance level (alpha value) was set at 0.05 with 5% acceptance as probability of not having the statistically significant difference.[11]
Type of publication | Total of CPA* | Mean CPA (Total CPA/30) |
SD | Variance |
---|---|---|---|---|
1 | 799.17 | 26.64 | 21.73 | 472.36 |
2A | 458.68 | 15.29 | 8.38 | 70.27 |
2B | 445.61 | 14.88 | 16.05 | 257.65 |
RESULTS
Thirty authors published 579 publications during 2010–2015. The average CPA for OA publications (category #1) was 11.35 higher than the average CPA of non-OA conventional publications with subscription (category #2A) (74% increase over 15.29) and 11.76 higher than the average CPA for non-OA conventional publications with free access (category #2B) (79% increase over 14.88) [Table 2 and Figure 2]. The citations for articles in OA (category #1) were statistically significantly higher (P < 0.05) than the articles published in conventional, non-OA, and journals with (category #2B) or without (category #2A) free access [Table 2 and Figure 2]. P value for comparison between category #1 and #2A was 0.010329766 and for comparison between category #1 and #2B was 0.020726153 [Table 2].
After a careful analysis of cytopathology articles published by 30 authors, 25 authors (author #1–25) revealed a higher citation per article average in the OA platform [Table 1]. Five authors (author #26–30), however, had lower CPA for OA articles (Chi-square P = 0.00001). Based on further scrutiny, most of the OA articles published by these five authors (author #26–30) (Table 1, remarks column #VII) were closer to 2015 with comparatively less time for accumulating citations. Slightly lower CPA for OA cytopathology articles by these authors appears to be due to this aberration. The publication pattern related to authors number 1–25 [Table 1] was relatively random with these authors showing tendency to prefer publishing in OA early in the career with accumulation of more citations.
DISCUSSION
The Budapest Declaration triggered by the meeting of the key players in favor of the OA movement stated that “new technology (has) converged to make possible an unprecedented public good.”[3] Utilizing the internet and OA principles allows access to more research than ever before with increase in OA publications and overall impact of OA in scientific literature.[12,13] Top publishers, governing agencies, as well as major scientific communities continue to advocate OA platform.[14]
In this study, analysis of 579 cytopathology-related articles showed that the average CPA for OA publications was 26.64. This average CPA for OA publications (category #1) showed higher than the average CPA with 74% increase as compared to non-OA conventional publications without free access. This increase was 79% as compared to the average CPA for non-OA conventional publications with free access [Table 2 and Figure 2].
As observed in Table 2 and Figure 2, CPAs for both categories #2A and #2B were lower than category #1. This highlights the recent trend that the scholars and authors are more interested in and prefer OA articles, irrespective of their free availability (category #2B). Other reason may be that many non-OA journals make the articles free after some time period, which discourages the preference to such articles by scholars and authors. Many experienced scholars appear to have understood the significance and benefits of not losing the copyright to their work generated as a result of hard work and efforts.
The slightly higher difference with category #2B and slight difference between category #2A and #2B was marginal, but it was not the topic of the study. This observation, however, highlights that OA publications attract higher CPA irrespective of free availability of non-OA publications (category #2B). One of the possible explanations for this observation is that many OA publications would allow barrier-free incorporation of diagrams, photographs, sketches, tables, etc., from OA articles in their manuscripts.
As confirmed by this study, OA publications translate in to increased citations. It has higher potential for wider collaboration, enabling researchers to carry out collaborative projects on global scale in public domain. With global access, the OA platform allows medical experts, authors, and readers to the enhanced discovery and treatment.
Table 3 shows number of views and downloads for 2020 articles in OA cytopathology journals (CytoJournal and Journal of Cytology) as recorded on July 24, 2021. The numbers for these articles in <1 year were significantly high for a small subspecialty like cytopathology. However, these data were not available for non-OA publications in the public domain and so could not be compared [Table 3]. In contrast to the non-OA publications, these and other parameters related to all OA publications can be retrieved easily in real time on web in public domain. This has many benefits, including auditing and confirmation of impact parameters at author or journal level. Publications cited in curriculum vitae under evaluation for scholarly progress can be easily scrutinized transparently (by allowing access to various statistical data in real time) if they are in OA. This may not be possible with non-OA category, even for those with free access.
Year | Views | Dwlds | ||
---|---|---|---|---|
CytoJournal Views/#Articles |
J of Cytology Views/#Articles |
CytoJournal Dwlds/#Articles |
J of Cytology Dwlds/#Articles |
|
2020 | 104706/28 | 82807/48 | 35222/28 | 7842/48 |
Average per article | 3739 | 1725 | 1258 | 163 |
One primary advantage of OA to the scientific medical community includes availability of reasonably equitable platform for authors and readers. A study highlights more cited articles under OA[13] with a substantial percentage of literature available through search engines such as Google Scholar[15] and other specialized services such as PubMed[9] and Research Index[16] extending powerful search methods available recently to general public at global level in public domain. A general understanding suggests that the peer-reviewed OA publications lead to higher rates of citation which has been reported by several publications.[12,13] A citation is defined as “a reference to the source of information used in one’s research.”[8] The majority of authors strive to be seen as an “authoritative source” and their work as “substantial.” The citations are crucial metric in determining the success of both authors and journals.
CONCLUSION
This study demonstrates that, in the field of cytopathology, the authors who published in OA journals during 5-year period from 2010 to 2015 accrued a higher citation rate as compared to the conventional non-OA cytopathology journals even if they were free access articles [Table 2].
Acknowledgment
Authors thank Scott Banks, Sr. Validation Specialist and Rajesh Dave, Validation Manager, Merck Animal Health Millsboro, DE for statistical support and logistic support. We also thank Kathy Rost and Dr. Ifrah Ahmed (Cytopathology Fellow) for secretarial and copy editing support, respectively.
COMPETING INTEREST STATEMENT BY ALL AUTHORS
JK does not have conflicts of interest to declare. VS is Coeditor -in-chief of CytoJournal (so the manuscript review process was conducted by Academic Editor designated for this manuscript).
AUTHORSHIP STATEMENT BY ALL AUTHORS
Each author has participated sufficiently in the work and takes responsibility for appropriate portions of the content of this article. All authors read and approved the final manuscript.
ETHICS STATEMENT BY ALL AUTHORS
The study does not need IRB approval as it is based on public domain data.
LIST OF ABBREVIATIONS (In alphabetic order)
APC: Article publication cost
CCCL: Creative commons copyright license
CF: Cytopathology foundation
CPA: Citations per article
Dwlds: Downloads IP: Intellectual property
JASC: Journal of American Cytopathology
J of Cytology: Journal of Cytology
non-OA: Non-open access
OA: Open access
EDITORIAL/PEER-REVIEW STATEMENT
CytoJournal editorial team thanks the academic editor: Andre Kajdacsy-Balla, MD, PhD. Professor and Director of Transdisciplinary Pathology, Department of Pathology, UIC College of Medicine, Chicago, IL, USA, for organizing and completing the peer-review process in timely manner for this manuscript as per CytoJournal peer-review policy.
References
- “Open Access Overview”. 2012. Available from: https://archive.org/details/9780262517638OpenAccess/page/n13/mode/2up [Last accessed on 2021 Aug 23]
- [CrossRef] [Google Scholar]
- 2012. Cambridge, Massachusetts: MIT Press; Available from: http://www.bit.ly/oa-book [Last accessed on 2021 Jul 19]
- [Google Scholar]
- Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals-a five year (2007-2011) experience. Cytojournal. 2014;11:10.
- [CrossRef] [PubMed] [Google Scholar]
- CMAS Books (CytoJournal) 2021. Available from: https://www.cytojournal.com/monographs [Last accessed on 2021 Jul 20]
- [Google Scholar]
- CellBlockistry 101 (CMAS #1) 2021. Available from: https://www.cytojournal.com/product/cellblockistry-101-cmas-1 [Last accessed on 2021 Jul 20]
- [Google Scholar]
- 2021. CytoJournal Monograph (CMAS). (1st ed). Cytopathology Foundation Inc; Available from: https://www.cytojournal.com/eissues [Last accessed on 2021 Jul 24]
- [Google Scholar]
- CytoJournal monographs: First CMAS (CytoJournal Monograph/Atlas Series) on science of cell-block making, titled CellBlockistry 101 (Text Book of Cell-blocking science) Cytojournal. 2021;18:10.
- [CrossRef] [PubMed] [Google Scholar]
- Research Skills Tutorial, Sunny Empire. Citation Definition. Available from: https://www.subjectguides.esc.edu/researchskillstutorial/citationparts [Last accessed on 2021 Jul 20]
- [Google Scholar]
- Available from: https://www.pubmed.ncbi.nlm.nih.gov [Last accessed on 2021 Jul 20]
- T-test. Available from: https://www.investopedia.com/terms/t/t-test.asp [Last accessed on 2021 Aug 04]
- [Google Scholar]
- What is it? Statistics How To. 2021. Available from: https://www.statisticshowto.com/probability-and-statistics/statistics-definitions/what-is-an-alpha-level [Last accessed on 2021 Jul 24]
- [Google Scholar]
- Free online availability substantially increases a paper's impact. Nature. 2001;411:521.
- [CrossRef] [PubMed] [Google Scholar]
- Is the open access citation advantage real? A systematic review of the citation of open access and subscription-based articles. PLoS One. 2021;16:e0253129.
- [CrossRef] [PubMed] [Google Scholar]
- Open Access Publishing and Resources, NIH Public Access Policy. 2021. Available from: https://www.guides.dml.georgetown.edu/openaccess/NIHOpenAccess [Last accessed on 2021 Aug 15]
- [Google Scholar]
- Google Scholar. Available from: https://www.scholar.google.com [Last accessed on 2021 Jul 20]
- [Google Scholar]
- Research Index. Available from: https://www.anl.gov/research-index [Last accessed on 2021 Jul 20]
- [Google Scholar]